发明授权
US08404709B2 Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof
有权
取代的4-芳基-1,4-二氢-1,6-萘啶及其用途
- 专利标题： Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof
- 专利标题（中）： 取代的4-芳基-1,4-二氢-1,6-萘啶及其用途
-
申请号： US12303719申请日： 2007-06-01
-
公开(公告)号： US08404709B2公开(公告)日： 2013-03-26
- 发明人: Santiago Figueroa Perez , Peter Kolkhof , Lars Bärfacker , Ingo Flamme , Karl-Heinz Schlemmer , Rolf Grosser , Klaus Münter , Andreas Knorr , Adam Nitsche
- 申请人： Santiago Figueroa Perez , Peter Kolkhof , Lars Bärfacker , Ingo Flamme , Karl-Heinz Schlemmer , Rolf Grosser , Klaus Münter , Andreas Knorr , Adam Nitsche
- 申请人地址： DE Monheim
- 专利权人： Bayer Intellectual Property GmbH
- 当前专利权人： Bayer Intellectual Property GmbH
- 当前专利权人地址： DE Monheim
- 代理商 Karen B. King; Thomas C. Blankinship
- 国际申请： PCT/EP2007/004865 WO 20070601
- 国际公布： WO2007/140934 WO 20071213
- 主分类号： A01N43/42
- IPC分类号： A01N43/42 ; A61K31/44 ; C07D471/02
摘要：
The present application relates to novel substituted 4-aryl-1,4-dihydro-1,6-naphthyridines, a process for their preparation, their use for the treatment and/or prophylaxis of diseases, and their use for the manufacture of medicaments for the treatment and/or prophylaxis of diseases, especially cardiovascular disorders.